CPT® Code 90683

1. Indications

The respiratory syncytial virus vaccine (CPT® Code 90683) is indicated for the prevention of respiratory syncytial virus infections, particularly in populations at higher risk. The following conditions and demographics are explicitly recognized for vaccination:

• Infants and Young Children: The vaccine is primarily aimed at protecting infants and young children who are particularly susceptible to RSV infections.
• Older Adults: Individuals in older age groups, who may have weakened immune systems or other health issues, are also at risk and can benefit from vaccination.
• Immunocompromised Individuals: Those with compromised immune systems due to various medical conditions or treatments are advised to receive the vaccine to reduce the risk of severe RSV infection.
• Individuals with Chronic Conditions: Patients with underlying health conditions such as diabetes, congestive heart failure, asthma, or chronic obstructive pulmonary disease (COPD) are at increased risk for complications from RSV and are recommended to be vaccinated.

2. Procedure

The administration of the respiratory syncytial virus vaccine involves several key procedural steps, which are outlined as follows:

• Step 1: Preparation of the Vaccine The vaccine must be prepared according to the manufacturer's guidelines, ensuring that it is stored at the appropriate temperature and is not expired. This includes checking the vial for any visible particles or discoloration before use.
• Step 2: Patient Assessment Prior to administration, a thorough assessment of the patient’s medical history is conducted to confirm eligibility for vaccination. This includes reviewing any allergies, previous reactions to vaccines, and current health status.
• Step 3: Administration of the Vaccine The vaccine is administered intramuscularly, typically in the deltoid muscle of the upper arm for adults and older children, or in the anterolateral thigh for infants and young children. The injection site is cleaned with an antiseptic wipe to minimize the risk of infection.
• Step 4: Post-Administration Monitoring After the vaccine is administered, the patient is monitored for a short period to observe for any immediate adverse reactions. This is particularly important for individuals with a history of allergic reactions to vaccines.

3. Post-Procedure

Following the administration of the respiratory syncytial virus vaccine, patients are advised on post-procedure care and what to expect. Commonly, mild side effects such as soreness at the injection site, low-grade fever, or fatigue may occur, which typically resolve within a few days. Patients should be informed to report any unusual or severe reactions, such as difficulty breathing or swelling, to their healthcare provider immediately. Additionally, it is recommended that patients keep a record of their vaccination for future reference and follow up with their healthcare provider for any necessary booster doses or additional vaccinations as per public health guidelines.